Autolus Therapeutics plc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,187.8% | +39.7% | -38.3% | +0.0% | +178.2% | -41.0% | -12.1% | +311.0% | -72.6% | +496.0% | +646.7% | |
| – | – | +111.1% | +4,686.8% | +0.0% | +118.3% | +28.0% | -4.6% | +6.7% | -95.2% | +2,048.1% | -31.5% | |
| – | +679.9% | -6.8% | -7,008.4% | – | – | – | – | +311.0% | -72.6% | -7,809.1% | – | |
| – | +380.3% | +53.4% | +53.9% | +0.0% | +328.7% | +27.8% | -17.9% | +5.9% | +11.2% | +21.2% | -18.7% | |
| – | -14.8% | +76.6% | +85.1% | +0.0% | +134.2% | -11.4% | -8.9% | +0.1% | +46.5% | +116.2% | +30.5% | |
| – | +90.1% | +61.1% | +65.2% | +0.0% | +249.7% | +17.2% | -16.5% | +5.1% | +21.7% | -39.1% | +135.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -22.4% | -66.7% | +0.0% | +8,962.9% | +64.5% | -41.5% | +705.9% | +406.1% | -79.4% | +295.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -259.4% | – | +369.0% | -107.0% | – | -666.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.